Last Price Today's Change   Day's Range   Trading Volume
0.62   +0.01 (1.64%)  0.61 - 0.64  1,788,600
Trade this stock with T+7 trading account. Find out more.


Market Cap: 197 Million
NOSH: 318 Million
Avg Volume (4 weeks):2,006,935
4 Weeks Range:0.52 - 0.665
4 Weeks Price Volatility (%):
52 Weeks Range:0.28 - 0.665
52 Weeks Price Volatility (%):
Average Price Target: 0.71
Price Target Upside/Downside: +0.09

Financial Highlight

Latest Quarter | Ann. Date 30-Jun-2019 [#4]  |  26-Aug-2019
Next QR | Est. Ann. Date: 30-Sep-2019  |  29-Nov-2019
T4Q P/E | EY: 16.98  |  5.89%
T4Q DY | Payout %: 0.81%  |  13.69%
T4Q NAPS | P/NAPS: 0.24  |  2.58
T4Q NP Margin | ROE: 39.27%  |  15.22%


Date Subject
08-Oct-2019 Trading Stocks - Nova Wellness Group
01-Oct-2019 Trading Stocks - Nova Wellness Group
08-Sep-2019 Nova Wellness Group- The next shining GEMS?

Business Background

Nova Wellness Group Bhd is engaged in providing dietary supplements which include vitamin, mineral, and herbal supplements, functional food products under brand name activmax and sustinex, and skincare products sold under brands novavis and SP8.
Analyze this stock with MQ Trader system

  Be the first to like this.
Up_down You are too ambitious..It's good enough if market cap grows until on par with Aheath.

Posted by stockraider > Sep 20, 2019 10:12 AM | Report Abuse

Yes general raider bought some at rm 0.540 to rm 0.545, in 5 yrs time this can be a new nestle loh...!!
20/09/2019 10:16 AM
LiimInvest TP > 0.70
20/09/2019 10:35 PM
LuckyBertuah Why to enter at 0.53? really hope someone sell to me at 520-525 on monday
29/09/2019 9:15 AM
123456 Enjin start
30/09/2019 10:45 AM
shortinvestor77 Seen Like
30/09/2019 11:24 AM
30/09/2019 11:35 AM
Up_down Momentum is backed after flushing out weak holders. Go go go!
30/09/2019 2:09 PM
Armada An Quantum Leap Stock In 2019/2020 Ubi diam diam selalunya manis rasanya
01/10/2019 2:26 PM
shortinvestor77 Stable price.
03/10/2019 8:02 AM
Up_down Diam diam beli sampai hot hot baru jual.
03/10/2019 3:27 PM
slts 0.71
04/10/2019 10:00 AM
tudungpink senin kne mek 100 taman
04/10/2019 6:30 PM
slts ttoday 0.60 wall collapse
07/10/2019 8:48 AM
shortinvestor77 Shooting up.
07/10/2019 9:13 AM
Up_down Price is still trending upward regardless of small number of voices. Waiting patiently.
07/10/2019 9:38 AM
张晋荣 It will sudden spike up and cross 0.670... watch closely...
07/10/2019 10:16 AM
07/10/2019 10:52 AM
HantuRaya2020 Y naik? Got any good announcement we miss?
07/10/2019 12:06 PM
Armada An Quantum Leap Stock In 2019/2020 0.760 - 0.815 to be conquered
07/10/2019 1:37 PM
Miz Raya Bloom I need vitamins!
08/10/2019 11:57 AM
magic01 Nova is now fundamentally and both technically good. Just wait for the good news.
08/10/2019 4:45 PM
shortinvestor77 I suggest you attend AGM. You will get a lot of vitamins. Nova had generously given last year.

Posted by Miz Raya Bloom > Oct 8, 2019 11:57 AM | Report Abuse

I need vitamins!
08/10/2019 7:34 PM
Miz Raya Bloom I NEED VITAMINS SPECIAL SUPPLEMENTS HEALTHY FOOD. https://www.facebook.com/Nova2U/
09/10/2019 9:52 AM
shortinvestor77 GO AGM.
09/10/2019 11:52 AM
10/10/2019 9:53 AM
magic01 Now nova edi stay strong. Stay tune.
10/10/2019 12:41 PM
Up_down Share price remains trending upward. Go Go Go!
10/10/2019 3:39 PM
magic01 Now nova is slowly climbing. Stay tune.
10/10/2019 5:06 PM
shortinvestor77 Once Nova product hepar-p passes all clinical tests, the share price will boom a few folds.
10/10/2019 9:03 PM
shortinvestor77 http://nova.my/product-details?product=98
10/10/2019 9:03 PM
Up_down Why Nova is allowed to sell hepar-p in the market since all clinical tests has not been passed?

Once Nova product hepar-p passes all clinical tests, the share price will boom a few folds.
10/10/2019 9:03 PM
11/10/2019 10:47 AM
shortinvestor77 The Group recorded revenue of RM9.63 million for the current quarter under review compared to RM8.06 million for the
preceding quarter. The increase of 19.5% was mainly due to higher sales contribution from House Brand segment under
the functional food category namely ActivMax and sales contribution from clinical trial for Hepar-P.

11/10/2019 5:28 PM
shortinvestor77 Clinical trial of Hepar-P Capsule ( is for the treatment of non-alcoholic fatty liver disease.
Completed the first clinical trial of Hepar-P Capsule for the treatment of non-alcoholic fatty liver disease.
Ready for the second clinical trial of Hepar-P Capsule for the treatment of non-alcoholic fatty liver disease.
11/10/2019 5:32 PM
shortinvestor77 as natural supplement without harm, no problem, it can be sold. But to prove its effectiveness to cure a disease, clinical test is needed for the product in order to claim it.
11/10/2019 5:36 PM
shortinvestor77 Nova uses Phyllanthus niruri (dukung anak) (easily found in Malaysia) for Hepar-P capsule.
Liver care is as complex as the liver itself. Hepar-P is a natural liver tonic agent, formulated with a standardized extract of Phyllanthus niruri and holds two Malaysian patents. Hepar-P provides a consistent dose of the functional actives, responsible for protecting the liver from injury.
11/10/2019 5:40 PM
Up_down It may take years to get through 5 phases clinical trials .

Phases of clinical trials
A clinical trial is only done when there is good reason to believe that a new test or treatment may improve the care of patients. Before clinical trials, tests and treatments are assessed in preclinical research. Preclinical research is not done with people. It assesses the features of a test or treatment. For example, the research may aim to learn if a device is harmful to living tissue. Another aim may be to learn more about the chemical makeup of a drug.

After preclinical research, tests and treatments go through a series of clinical trials. Clinical trials assess if tests or treatments are safe for and work in people. Clinical trials have five phases. The phases are described next using the example of a new drug treatment:

Phase 0
Phase 0 trials are the first clinical trials done among people. They aim to learn how a drug is processed in the body and how it affects the body. In these trials, a very small dose of a drug is given to about 10 to 15 people.

Phase I
Phase I trials aim to find the best dose of a new drug with the fewest side effects. The drug will be tested in a small group of 15 to 30 patients. Doctors start by giving very low doses of the drug to a few patients. Higher doses are given to other patients until side effects become too severe or the desired effect is seen. The drug may help patients, but Phase I trials are to test a drug’s safety. If a drug is found to be safe enough, it can be tested in a phase II clinical trial.

Phase II
Phase II trials further assess safety as well as if a drug works. The drug is often tested among patients with a specific type of cancer. Phase II trials are done in larger groups of patients compared to Phase I trials. Often, new combinations of drugs are tested. Patients are closely watched to see if the drug works. However, the new drug is rarely compared to the current (standard-of-care) drug that is used. If a drug is found to work, it can be tested in a phase III clinical trial.

Phase III
Phase III trials compare a new drug to the standard-of-care drug. These trials assess the side effects of each drug and which drug works better. Phase III trials enroll 100 or more patients.

Often, these trials are randomized. This means that patients are put into a treatment group, called trial arms, by chance. Randomization is needed to make sure that the people in all trial arms are alike. This lets scientists know that the results of the clinical trial are due to the treatment and not differences between the groups. A computer program is often used to randomly assign people to the trial arms.

There can be more than two treatment groups in phase III trials. The control group gets the standard-of-care treatment. The other groups get a new treatment. Neither you nor your doctor can choose your group. You will also not know which group you’re in until the trial is over.

Every patient in a phase III study is watched closely. The study will be stopped early if the side effects of the new drug are too severe or if one group has much better results. Phase III clinical trials are often needed before the FDA will approve the use of a new drug for the general public.

Phase IV
Phase IV trials test new drugs approved by the FDA. The drug is tested in several hundreds or thousands of patients. This allows for better research on short-lived and long-lasting side effects and safety. For instance, some rare side effects may only be found in large groups of people. Doctors can also learn more about how well the drug works and if it’s helpful when used with other treatments.
11/10/2019 6:07 PM
Up_down If Hepar-P is able to complete 3rd clinical trials, MNC may come to take over Nova. lolz

Posted by shortinvestor77 > Oct 11, 2019 5:32 PM | Report Abuse

Clinical trial of Hepar-P Capsule ( is for the treatment of non-alcoholic fatty liver disease.
Completed the first clinical trial of Hepar-P Capsule for the treatment of non-alcoholic fatty liver disease.
Ready for the second clinical trial of Hepar-P Capsule for the treatment of non-alcoholic fatty liver disease.
11/10/2019 6:21 PM
shortinvestor77 Nova Wellness bosses have a large portion of shares, unabled to be taken over easily by multi national companies lah. Anyhow, they can start buying now aa you can see the share price is uptrend.
11/10/2019 9:41 PM
Armada An Quantum Leap Stock In 2019/2020 Up down sifu
Give you 1 like
For the facts sharing
11/10/2019 9:48 PM
Up_down Nova is going to undertake a 3rd clinical trial for Hepar-P Capsule costing RM 2.5 million within 24 months.
11/10/2019 10:41 PM
Up_down Share price up like nobody business. First TP 76 cents.
14/10/2019 11:12 AM
15/10/2019 10:01 AM
CASHCOWINVESTOR Buy before regret
15/10/2019 10:10 AM
Up_down Not many small retailers invest in Nova. Therefore, it seems like nobody business when the share prices has been rising all the way up. Funds manager are quietly accumulating.
15/10/2019 11:00 AM
Armada An Quantum Leap Stock In 2019/2020 Today closing at 0.630 

Firm support at 0.600 
Immediate target to hit 0.710 

Risk over Reward : 1 to 3 
The probability of win is more than your meal for a day. 
In another word, entry at 0.630 u chance to win just like eating lettuce. 

17/10/2019 12:55 AM
17/10/2019 6:29 PM
cheer76 topup
17/10/2019 11:10 PM
Armada An Quantum Leap Stock In 2019/2020 Nova making a return again
Real good
18/10/2019 9:58 AM
Up_down It rebounded so fast. Last time, the price retreated from 60 cents to 52.5 cents.
18/10/2019 10:39 AM
Up_down Financial facts of Nova Wellness:
Price: 0.64
PER: 21x
Gearing: Nil
Dividend yield: 3.6% ( 2.3 cents per share)

Net cash generated from operating activities:
FY 30 Jun 2019 - 13.3m
FY 30 Jun 2018 - 7.1m

30 Sep 19 - ???
30 Jun 19 - 3.71m ( excluding IPO expenses, reversal of slow moving stock & interest received)
31 Mar 19 - 2.03m
31 Dec 18 - 3.08m
30 Sep 18 - 0.85m
30 Jun 18 - 2.41m
31 Mar 18 - 1.38m

30 Sep 19 - ???
30 Jun 19 - 9.6m
31 Mar 19 - 7.2m
31 Dec 18 - 7.9m
30 Sep 18 - 4.8m
30 Jun 18 - 8.1m
31 Mar 18 - 4.7m
18/10/2019 11:09 AM


413  296  522  772 

Top 10 Active Counters
 KNM 0.455+0.01 
 PUC 0.0550.00 
 MTAG 0.51+0.025 
 SAPNRG 0.27-0.005 
 ARMADA 0.445+0.005 
 MYEG 1.26+0.01 
 GPACKET-WB 0.325+0.005 
 KNM-WB 0.185+0.005 
 HSI-C7F 0.335-0.035 
 HSI-H8B 0.205+0.02 
Partners & Brokers